March 24, 2020 / 12:23 PM / in 7 days

BRIEF-Aldeyra To Screen Clinical-Stage Compounds For Activity In COVID-19 Infection

March 24 (Reuters) - Aldeyra Therapeutics Inc:

* ALDEYRA TO SCREEN CLINICAL-STAGE COMPOUNDS FOR ACTIVITY IN COVID-19 INFECTION

* ALDEYRA - TO BEGIN SCREENING LIBRARY OF NOVEL RASP INHIBITORS, FOR POTENTIAL ANTI-INFLAMMATORY & ANTIVIRAL ACTIVITY IN TREATMENT OF COVID-19 INFECTION

* ALDEYRA THERAPEUTICS INC - SUBMITTED A PROPOSAL TO BARDA FOR DEVELOPMENT OF ADX-629 FOR TREATMENT OF COVID-19 INFECTION

* ALDEYRA THERAPEUTICS INC - ALSO SEEKING HEALTHCARE INDUSTRY PARTNERS THAT MAY BE INTERESTED IN TESTING ADX-629 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below